2024-09-20 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a healthcare company that operates pharmacies, retail stores, and healthcare services.

**Performance Analysis:**

1. **Performance vs S&P 500:**  
    CVS has underperformed significantly compared to the S&P 500 (VOO) over the analyzed period. The cumulative return of CVS is -33.8%, while the S&P 500 has returned 128.99%. This results in a substantial performance gap of -162.79%. This difference places CVS at the 1.31 percentile in terms of its relative performance against the S&P 500, indicating a significantly lower performance compared to its historical range.

2. **Recent Price Movement:** 
    * **Closing Price:** 58.42
    * **5-Day Moving Average:** 58.0
    * **20-Day Moving Average:** 57.72
    * **60-Day Moving Average:** 58.31
    The current price is slightly above the 5-day and 20-day moving averages, suggesting short-term bullish sentiment. However, the 60-day moving average being slightly higher indicates a potential for a pullback to the long-term average.

3. **Technical Indicators:**
    * **RSI:** 55.66 (Neutral)
    * **PPO:** 0.23 (Slight Bullish)
    * **Delta_Previous_Relative_Divergence:** -0.33 (Short-term downward trend)
    * **Expected Return:** 14.4% (Potential maximum 5-year expected return)
    The RSI suggests a neutral market, while the PPO indicates a slight bullish bias. The negative Delta_Previous_Relative_Divergence signifies a recent decline in the short-term relative strength. Despite this, the expected return of 14.4% remains positive.

4. **Recent Earnings Performance:**
    | Date | EPS | Expected EPS |
    |---|---|---|
    | 2024-08-07 | 1.83 | 1.73 |
    | 2024-05-01 | 1.31 | 1.7 |
    | 2024-02-07 | 2.12 | 2.01 |
    | 2023-11-01 | 2.21 | 2.13 |
    | 2023-08-02 | 2.21 | 2.12 |

    CVS has consistently exceeded earnings expectations in the past few quarters. However, the most recent earnings report (2024-08-07) shows a slight decrease in EPS compared to previous quarters, despite exceeding expectations. Further analysis of the company's guidance and market outlook is needed to gauge the future earnings trajectory.

**Overall Analysis:**

CVS has shown a significant underperformance compared to the S&P 500, demonstrating its struggle to keep pace with broader market trends. While recent technical indicators point to a neutral to slightly bullish sentiment, a short-term downward trend is observed. However, the expected return remains positive, highlighting the potential for future growth. The company has consistently exceeded earnings expectations in recent quarters, but the most recent earnings report indicates a slight decline in EPS. Further analysis of the company's financial statements, future guidance, and market conditions is crucial to assess the potential investment opportunities for CVS. 
